Dr Sreekumar Madassery, MD | |
1725 W. Congress Parkway, Ste 450, Chicago, IL 60612 | |
(312) 563-4238 | |
Not Available |
Full Name | Dr Sreekumar Madassery |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 19 Years |
Location | 1725 W. Congress Parkway, Chicago, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063649093 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0204X | Radiology - Vascular & Interventional Radiology | 036134949 (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Rush University Medical Center | Chicago, IL | Hospital |
Rush Oak Park Hospital | Oak park, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Rush University Medical Center | 5496658874 | 1007 |
News Archive
Savient Pharmaceuticals, Inc. announced that its previously announced process to identify, following the approval of KRYSTEXXA by the U.S. Food and Drug Administration (FDA), a strategic transaction for the sale of the Company did not result in a sale of the Company at this time. The board of directors will continue to evaluate strategic alternatives available to the Company to maximize value.
A novel type of contrast-enhanced magnetic resonance (MR) angiography is highly accurate in identifying blockages in the arteries that carry blood to the brain, according to a study in the February issue of Radiology.
Rhythm announced today the initiation of two Phase 2 clinical trials focused on evaluating the safety and effectiveness of setmelanotide (RM-493), the company's novel melanocortin 4 receptor (MC4R) agonist, for the treatment of Prader-Willi Syndrome (PWS) and POMC-null obesity.
Dartmouth Linguistics Professor Lewis Glinert and Jon Schommer, the associate head of the Department of Pharmaceutical Care and Health Systems at the University of Minnesota, have examined the corporate websites dedicated to the 100 best-selling prescription drugs. They found a startling lack of consistency in an industry where advertising standards are regulated by the Food and Drug Administration.
› Verified 6 days ago
Entity Name | Rockford Health Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043242886 PECOS PAC ID: 2567374036 Enrollment ID: O20031103000584 |
News Archive
Savient Pharmaceuticals, Inc. announced that its previously announced process to identify, following the approval of KRYSTEXXA by the U.S. Food and Drug Administration (FDA), a strategic transaction for the sale of the Company did not result in a sale of the Company at this time. The board of directors will continue to evaluate strategic alternatives available to the Company to maximize value.
A novel type of contrast-enhanced magnetic resonance (MR) angiography is highly accurate in identifying blockages in the arteries that carry blood to the brain, according to a study in the February issue of Radiology.
Rhythm announced today the initiation of two Phase 2 clinical trials focused on evaluating the safety and effectiveness of setmelanotide (RM-493), the company's novel melanocortin 4 receptor (MC4R) agonist, for the treatment of Prader-Willi Syndrome (PWS) and POMC-null obesity.
Dartmouth Linguistics Professor Lewis Glinert and Jon Schommer, the associate head of the Department of Pharmaceutical Care and Health Systems at the University of Minnesota, have examined the corporate websites dedicated to the 100 best-selling prescription drugs. They found a startling lack of consistency in an industry where advertising standards are regulated by the Food and Drug Administration.
› Verified 6 days ago
Entity Name | Rush University Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093819542 PECOS PAC ID: 5496658874 Enrollment ID: O20040202000228 |
News Archive
Savient Pharmaceuticals, Inc. announced that its previously announced process to identify, following the approval of KRYSTEXXA by the U.S. Food and Drug Administration (FDA), a strategic transaction for the sale of the Company did not result in a sale of the Company at this time. The board of directors will continue to evaluate strategic alternatives available to the Company to maximize value.
A novel type of contrast-enhanced magnetic resonance (MR) angiography is highly accurate in identifying blockages in the arteries that carry blood to the brain, according to a study in the February issue of Radiology.
Rhythm announced today the initiation of two Phase 2 clinical trials focused on evaluating the safety and effectiveness of setmelanotide (RM-493), the company's novel melanocortin 4 receptor (MC4R) agonist, for the treatment of Prader-Willi Syndrome (PWS) and POMC-null obesity.
Dartmouth Linguistics Professor Lewis Glinert and Jon Schommer, the associate head of the Department of Pharmaceutical Care and Health Systems at the University of Minnesota, have examined the corporate websites dedicated to the 100 best-selling prescription drugs. They found a startling lack of consistency in an industry where advertising standards are regulated by the Food and Drug Administration.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Sreekumar Madassery, MD 933 W Van Buren St, Unit 705, Chicago, IL 60607-3588 Ph: (708) 359-1047 | Dr Sreekumar Madassery, MD 1725 W. Congress Parkway, Ste 450, Chicago, IL 60612 Ph: (312) 563-4238 |
News Archive
Savient Pharmaceuticals, Inc. announced that its previously announced process to identify, following the approval of KRYSTEXXA by the U.S. Food and Drug Administration (FDA), a strategic transaction for the sale of the Company did not result in a sale of the Company at this time. The board of directors will continue to evaluate strategic alternatives available to the Company to maximize value.
A novel type of contrast-enhanced magnetic resonance (MR) angiography is highly accurate in identifying blockages in the arteries that carry blood to the brain, according to a study in the February issue of Radiology.
Rhythm announced today the initiation of two Phase 2 clinical trials focused on evaluating the safety and effectiveness of setmelanotide (RM-493), the company's novel melanocortin 4 receptor (MC4R) agonist, for the treatment of Prader-Willi Syndrome (PWS) and POMC-null obesity.
Dartmouth Linguistics Professor Lewis Glinert and Jon Schommer, the associate head of the Department of Pharmaceutical Care and Health Systems at the University of Minnesota, have examined the corporate websites dedicated to the 100 best-selling prescription drugs. They found a startling lack of consistency in an industry where advertising standards are regulated by the Food and Drug Administration.
› Verified 6 days ago
Dr. Benjamin Jordan Meyer, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 7435 W Talcott Ave, Chicago, IL 60631 Phone: 773-774-8000 | |
Lauren Elizabeth Arsenault, MD Radiology Medicare: Medicare Enrolled Practice Location: 1653 W Congress Pkwy, Chicago, IL 60612 Phone: 312-942-5781 Fax: 312-942-7244 | |
Dr. Mohan Phatak, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 7435 W Talcott Ave, Chicago, IL 60631 Phone: 773-792-5138 Fax: 773-792-5124 | |
Janice Dieschbourg, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St, Suite 155, Chicago, IL 60612 Phone: 312-563-3269 | |
Amir K Sepahdari, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5145 N California Avenue, Swedish Covenant Hospital, Chicago, IL 60625 Phone: 773-989-3814 Fax: 773-989-6230 | |
Dr. Amar Pravin Shah, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 461, Chicago, IL 60612 Phone: 312-942-5781 | |
Dr. Naveen Prabhakar, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 836 W Wellington Ave, Chicago, IL 60657 Phone: 773-296-7820 Fax: 773-296-7821 |